BusinessTempus and University of California Davis Comprehensive Cancer Center Announce Personalized Medicine Partnership for Cancer PatientsBy Nasdaq OMXAug 31, 2017, 2:00 PM UTC
BusinessImmune Design Announces New CMB305 + Checkpoint Inhibitor Topline Data from an Upcoming Presentation at the ESMO 2017 CongressBy Nasdaq OMXAug 30, 2017, 10:42 PM UTC
BusinessCascadian Therapeutics Announces Poster Presentations on Tucatinib in Multiple Tumor Types at the European Society for Medical Oncology (ESMO) 2017 CongressBy Nasdaq OMXAug 28, 2017, 12:30 PM UTC
BusinessTESARO Announces Nine Data Presentations at the 2017 European Society for Medical Oncology (ESMO) Annual MeetingBy Nasdaq OMXAug 25, 2017, 12:01 PM UTC
BusinessCrown Bioscience Names Dr. Leon Hall Vice President of Global Scientific ExcellenceBy Nasdaq OMXAug 22, 2017, 12:00 PM UTC
BusinessTempus Selected as Sequencing and Analytics Provider by the Prostate Cancer Clinical Trials Consortium for Phase II Clinical TrialBy Nasdaq OMXAug 17, 2017, 1:00 PM UTC
BusinessOnconova Therapeutics, Inc. Reports Recent Business Highlights and Second Quarter 2017 Financial ResultsBy Nasdaq OMXAug 15, 2017, 11:00 AM UTC
BusinessCrown Bioscience Announces Second Quarter Results, Appoints Dr. Yangzhou Wang as Sr. VP of Global OperationsBy Nasdaq OMXAug 14, 2017, 4:00 AM UTC
